Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Grossman

Showing results (561-570 of 794) with videos related to

Pageof 80
Sort By:
Endocrinology|January 12, 2013
Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude miceAlessio Giubellino, Petra Bullova, Svenja Nölting, et al.
Clinical Endocrinology|January 29, 2000
Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndromeM A Satta, S M Corsello, S Della Casa, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humansSharmilee Gnanapavan, Blerina Kola, Stephen A Bustin, et al.
Molecular and Cellular Endocrinology|March 20, 2003
ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathwayDennis Norman, Andrea M Isidori, Vanni Frajese, et al.
Clinical Endocrinology|September 30, 2000
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year studyD Florakis, V Hung, G Kaltsas, et al.
Clinical Endocrinology|August 1, 1991
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndromeJ A Verhelst, P J Trainer, T A Howlett, et al.
The Journal of Urology|December 1, 1991
Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladderE Huland, H Huland, T Meier, et al.
Hormone Research|March 29, 2007
Factors influencing skeletal maturation at diagnosis of paediatric Cushing's diseaseC J Peters, M L Ahmed, H L Storr, et al.
The Journal of Pediatrics|September 14, 2016
Variation in Preventive Care in Children Receiving Chronic Glucocorticoid TherapyMatthew L Basiaga, Evanette K Burrows, Michelle R Denburg, et al.
Neuroendocrinology|November 21, 2007
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell LineSimona Grozinsky-Glasberg, Giulia Franchi, Mabel Teng, et al.
Pageof 80

Showing results (561-570 of 794) with videos related to

Sort By:
Pageof 80
Endocrinology|January 12, 2013
Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude miceAlessio Giubellino, Petra Bullova, Svenja Nölting, et al.
Clinical Endocrinology|January 29, 2000
Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndromeM A Satta, S M Corsello, S Della Casa, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humansSharmilee Gnanapavan, Blerina Kola, Stephen A Bustin, et al.
Molecular and Cellular Endocrinology|March 20, 2003
ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathwayDennis Norman, Andrea M Isidori, Vanni Frajese, et al.
Clinical Endocrinology|September 30, 2000
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year studyD Florakis, V Hung, G Kaltsas, et al.
Clinical Endocrinology|August 1, 1991
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndromeJ A Verhelst, P J Trainer, T A Howlett, et al.
The Journal of Urology|December 1, 1991
Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladderE Huland, H Huland, T Meier, et al.
Hormone Research|March 29, 2007
Factors influencing skeletal maturation at diagnosis of paediatric Cushing's diseaseC J Peters, M L Ahmed, H L Storr, et al.
The Journal of Pediatrics|September 14, 2016
Variation in Preventive Care in Children Receiving Chronic Glucocorticoid TherapyMatthew L Basiaga, Evanette K Burrows, Michelle R Denburg, et al.
Neuroendocrinology|November 21, 2007
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell LineSimona Grozinsky-Glasberg, Giulia Franchi, Mabel Teng, et al.
Pageof 80